These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12351486)

  • 1. Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes.
    Chiarelli F; Cipollone F; Mohn A; Marini M; Iezzi A; Fazia M; Tumini S; De Cesare D; Pomilio M; Pierdomenico SD; Di Gioacchino M; Cuccurullo F; Mezzetti A
    Diabetes Care; 2002 Oct; 25(10):1829-34. PubMed ID: 12351486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes.
    Cipollone F; Chiarelli F; Iezzi A; Fazia ML; Cuccurullo C; Pini B; De Cesare D; Torello M; Tumini S; Cuccurullo F; Mezzetti A
    Int J Immunopathol Pharmacol; 2005; 18(4):625-35. PubMed ID: 16388709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration.
    Chiarelli F; Cipollone F; Romano F; Tumini S; Costantini F; di Ricco L; Pomilio M; Pierdomenico SD; Marini M; Cuccurullo F; Mezzetti A
    Diabetes; 2000 Jul; 49(7):1258-63. PubMed ID: 10909986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.
    Banba N; Nakamura T; Matsumura M; Kuroda H; Hattori Y; Kasai K
    Kidney Int; 2000 Aug; 58(2):684-90. PubMed ID: 10916091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezetimibe reduces urinary albumin excretion in hypercholesterolaemic type 2 diabetes patients with microalbuminuria.
    Nakamura T; Sato E; Amaha M; Kawagoe Y; Maeda S; Inoue H; Yamagishi SI
    J Int Med Res; 2012; 40(2):798-803. PubMed ID: 22613445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K; Matsumoto S; Aso Y; Inukai T
    J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration.
    Apakkan Aksun S; Ozmen B; Ozmen D; Parildar Z; Senol B; Habif S; Mutaf I; Turgan N; Bayindir O
    J Diabetes Complications; 2003; 17(6):343-8. PubMed ID: 14583179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.
    Tam FW; Riser BL; Meeran K; Rambow J; Pusey CD; Frankel AH
    Cytokine; 2009 Jul; 47(1):37-42. PubMed ID: 19409809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients.
    Piarulli F; Sartore G; Ceriello A; Ragazzi E; Reitano R; Nollino L; Cosma C; Fedele D; Lapolla A
    Diabetologia; 2009 Jul; 52(7):1419-25. PubMed ID: 19401824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
    Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
    J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes.
    Jaffa AA; Durazo-Arvizu R; Zheng D; Lackland DT; Srikanth S; Garvey WT; Schmaier AH;
    Diabetes; 2003 May; 52(5):1215-21. PubMed ID: 12716755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of high-dose vitamin E supplementation on oxidative stress and microalbuminuria in young adult patients with childhood onset type 1 diabetes mellitus.
    Giannini C; Lombardo F; Currò F; Pomilio M; Bucciarelli T; Chiarelli F; Mohn A
    Diabetes Metab Res Rev; 2007 Oct; 23(7):539-46. PubMed ID: 17266173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Knowler WC; Rovin BH; Wu H; Klein JB; Mifflin TE; Feldman HI; Vasan RS; Kimmel PL; Kusek JW; Mauer M;
    Nephrol Dial Transplant; 2015 Apr; 30(4):599-606. PubMed ID: 25648911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic control and prognosis in type I diabetic patients with microalbuminuria.
    Bojestig M; Arnqvist HJ; Karlberg BE; Ludvigsson J
    Diabetes Care; 1996 Apr; 19(4):313-7. PubMed ID: 8729152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients.
    Dahlquist G; Stattin EL; Rudberg S
    Nephrol Dial Transplant; 2001 Jul; 16(7):1382-6. PubMed ID: 11427629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, double-blind clinical trial.
    Omidian M; Mahmoudi M; Javanbakht MH; Eshraghian MR; Abshirini M; Daneshzad E; Hasani H; Alvandi E; Djalali M
    Diabetes Metab Syndr; 2019; 13(5):2873-2877. PubMed ID: 31425951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple lipoprotein abnormalities in type I diabetic patients with renal disease.
    Groop PH; Elliott T; Ekstrand A; Franssila-Kallunki A; Friedman R; Viberti GC; Taskinen MR
    Diabetes; 1996 Jul; 45(7):974-9. PubMed ID: 8666151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy.
    Korpinen E; Groop PH; Fagerudd JA; Teppo AM; Akerblom HK; Vaarala O
    Diabet Med; 2001 Feb; 18(2):121-5. PubMed ID: 11251675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.